Stuarta Macgowan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study explores how human ACE2 variants can modify SARS-CoV-2 binding A recent tour-de-force study by researchers from the United Kingdom reveals variants of the human angiotensin-converting enzyme 2 (ACE2) that can improve or decrease binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – including two variants with distinct population distributions showing an enhanced affinity for viral spike glycoprotein. This research paper is currently available on the bioRxiv* preprint server while the article undergoes peer review. Since the start of the coronavirus disease 201...